Results 111 to 120 of about 2,487 (162)

Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions. [PDF]

open access: yesWorld J Clin Oncol
Christodoulidis G   +6 more
europepmc   +1 more source

Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome. [PDF]

open access: yesInt J Mol Sci
Donati S   +11 more
europepmc   +1 more source

Gastrinoma

Current Treatment Options in Oncology, 2001
Gastrinoma treatment has evolved considerably in the last 20 years. In particular, the advent of effective acid-reducing pharmacologic agents has changed the primary morbidity of this disease entity from one of acid hypersecretion to one of tumor growth and spread. Thus, while symptoms can be temporized using histamine receptor antagonists, proton pump
M L, Li, J A, Norton
openaire   +2 more sources

Gastrinoma

Surgical Clinics of North America, 1986
AbstractThe Zollinger‐Ellison syndrome with its main symptom of massive gastric hypersecretion presents problems with both the medical and surgical approaches to treatment. Successful medical treatment depends on a lifelong commitment to rigid medication schedules requiring careful ongoing supervision and is subject to pitfalls of compliance, drug side
C M, Townsend, J C, Thompson
openaire   +3 more sources

Surgery for Gastrinoma

Advances in Surgery, 2007
Surgery has been demonstrated to offer potential for cure in patients who have sporadic ZES and improved tumor-related survival in all patients who have ZES with gastrinomas larger than 2.5 cm. Techniques such as preoperative localization with SRS and intraoperative localization with duodenotomy have improved the effectiveness of surgical intervention ...
Robin M, Cisco, Jeffrey A, Norton
openaire   +2 more sources

Home - About - Disclaimer - Privacy